Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a revision tag update from v3.6.2 to v3.6.3, indicating a new build or patch applied to the study details display.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a minor metadata update to the page and does not change the study details presented.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment has ended. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the revision label changed to v3.6.0.SummaryDifference0.4%

- Check30 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's template or metadata rather than content changes. No substantive study information appears to be affected.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This reflects a page maintenance/version update and does not modify the study content or its presentation.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site build update rather than a change to the study record content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.